CGS.AX - Cogstate Limited

ASX - ASX Delayed Price. Currency in AUD
0.94
-0.02 (-2.08%)
At close: 3:18PM AEDT
Stock chart is not supported by your current browser
Previous Close0.96
Open0.97
Bid0.94 x 3009100
Ask0.98 x 750900
Day's Range0.94 - 0.97
52 Week Range0.79 - 1.39
Volume58,678
Avg. Volume51,347
Market Cap107.26M
Beta-0.24
PE Ratio (TTM)N/A
EPS (TTM)-0.01
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.27
  • Business Wirelast month

    Cogstate Announces First U.S. Deployment of the Cognigram™ System at the University of Notre Dame

    The cognitive science company, Cogstate today announced the commercial deployment of its Cognigram™ digital cognitive assessment system at the University of Notre Dame. This placement represents the first Cognigram system commercial implementation in the United States, following the recent FDA notification that the Company can begin marketing the system in the U.S.

  • Cogstate Ltd. :CGS-AU: Earnings Analysis: For the six months ended June 30, 2017 : August 25, 2017
    Capital Cube3 months ago

    Cogstate Ltd. :CGS-AU: Earnings Analysis: For the six months ended June 30, 2017 : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Cogstate Ltd. reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of Cogstate Ltd. – Pro Medicus Limited (PME-AU) that have also reported for this period. Highlights Summary numbers: Revenues of AUD 16.41 million, Net Earnings of AUD -1.79 million. Gross ... Read more (Read more...)

  • Cogstate Ltd. :CGS-AU: Earnings Analysis: 2017 By the Numbers : August 24, 2017
    Capital Cube3 months ago

    Cogstate Ltd. :CGS-AU: Earnings Analysis: 2017 By the Numbers : August 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Cogstate Ltd. reports financial results for the year ended June 30, 2017. We analyze the earnings along side the following peers of Cogstate Ltd. – Pro Medicus Limited (PME-AU) that have also reported for this period. Highlights Gross margins narrowed from 19.36% to 14.80% compared to the same period last year, ... Read more (Read more...)

  • Business Wire4 months ago

    Cogstate Receives Positive FDA Notification Regarding Medical Device Regulatory Submission

    The cognitive science company, Cogstate today announced that its healthcare division has received notification from the U.S. Food and Drug Administration that the Company’s 510 submission for the COGNIGRAM™ cognitive assessment system has been reviewed by the Center for Devices and Radiological Health and found to meet the requirements of regulations 21 CFR 882.1470; Class II Exempt Medical Device....

  • Business Wire6 months ago

    Cogstate Selected as Preferred Provider to Lilly’s Alzheimer’s Disease Platform

    The cognitive science company, Cogstate Ltd today announced it has been chosen as the preferred provider to the global healthcare leader, Eli Lilly and Company, to support their Alzheimer disease platform with solutions to ensure high-quality neuropsychological outcome measures in clinical trials.

  • Cogstate Ltd. :CGS-AU: Earnings Analysis: For the six months ended December 31, 2016 : March 16, 2017
    Capital Cube8 months ago

    Cogstate Ltd. :CGS-AU: Earnings Analysis: For the six months ended December 31, 2016 : March 16, 2017

    Categories: Yahoo Finance Get free summary analysis Cogstate Ltd. reports financial results for the half-year ended December 31, 2016. We analyze the earnings along side the following peers of Cogstate Ltd. – Pro Medicus Limited, Global Health Limited and Neuren Pharmaceuticals Limited (PME-AU, GLH-AU and NEU-AU) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)